HIGHLIGHTS
- who: Philip Q. Ding et al. from the breast cancer breast cancerin Patients with Breast Cancer from Alberta, Canada Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T G , Canada have published the research: Real-World Use of Granulocyte-Colony Stimulating Factorin Patients with Breast Cancer from Alberta, Canada, in the Journal: Cancers 2022, x of /2022/
- what: This study characterized real-world G-CSF use during the period surrounding the introduction of filgrastim biosimilar. The authors focused on patients with breast cancer due to the high incidence of FN in this population . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.